Abstract: New analogues of 3-Formyl-4-phenyl-1,2,5-oxadiazole N-oxide (1) are prepared and evaluated as cytotoxic selective agents in hypoxia.
Introduction
As part of our research project on biorreducible drugs in hypoxia conditions, we have developed a series of compound derivatives of N-oxide of 1,2,5-oxadiazoles system. They were evaluated as cytotoxic agents against V79 cells in oxia and hypoxic conditions. None of them showed selectivity in hypoxic conditions, but the derivative 1 presented a good profile of Cytotoxicity (Figure 1) . In order to gain insight the mechanism of action and to obtain a selective compound, we designed the following modifications. All the products were characterized by 1 H RMN, 13 C RMN, (1D, 2D), EM, IR and in same cases elemental microanalysis. The cytotoxicity of the synthesized products was tested against V79 cells in oxia and hipoxia conditions at a concentration of 20 µM, following a protocol previously described [1] .
Results and Discussion
All the synthetic procedures conducted to the products of interest with variable yields. As the drugmodulations previously described [2] , the new ones may asseverate that the substituent at the 3 position of the 1,2,5-oxadiazol N-oxide plays an important role in the cytotoxic activity of this kind of compounds. 
